Indication
COVID-19
COVID-19 (coronavirus disease 2019) is an acute infectious illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), primarily targeting the respiratory system but capable of causing multiorgan pathology. Read more about COVID-19
3 drugs 3 manufacturers
Drugs that treat it
Common COVID-19 therapies.
PAXLOVID (nirmatrelvir/ritonavir)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCOVID-19 (coronavirus disease 2019) is an acute infectious illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), primarily targeting the respiratory system but capable of causing multiorgan pathology.
The disease affects pediatric and adult populations, with older adults and individuals with underlying medical comorbidities experiencing the greatest risk of severe disease.
Pathophysiologically, the condition is driven by viral replication followed, in severe presentations, by a dysregulated systemic inflammatory response, endothelial injury, and coagulopathy.
Clinical manifestations range from asymptomatic infection or mild upper respiratory symptoms—such as fever, cough, fatigue, and anosmia—to acute hypoxemic respiratory failure, acute respiratory distress syndrome (ARDS), thromboembolic events, and death.
- medlineplus.gov
COVID-19 (coronavirus disease 2019) is an acute infectious illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), primarily targeting the respiratory system but capable of causing multiorgan pathology
- nih.gov
COVID-19 (coronavirus disease 2019) is an acute infectious illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), primarily targeting the respiratory system but capable of causing multiorgan pathology
- nih.gov
COVID-19 (coronavirus disease 2019) is an acute infectious illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), primarily targeting the respiratory system but capable of causing multiorgan pathology Pathophysiologically, the condition is driven by viral replication followed, in severe presentations, by a dysregulated systemic inflammatory response, endothelial injury, and coagulopathy Clinical manifestations range from asymptomatic infection or mild upper respiratory s...
- medlineplus.gov
The disease affects pediatric and adult populations, with older adults and individuals with underlying medical comorbidities experiencing the greatest risk of severe disease Clinical manifestations range from asymptomatic infection or mild upper respiratory symptoms—such as fever, cough, fatigue, and anosmia—to acute hypoxemic respiratory failure, acute respiratory distress syndrome (ARDS), thromboembolic events, and death
- nih.gov
The disease affects pediatric and adult populations, with older adults and individuals with underlying medical comorbidities experiencing the greatest risk of severe disease
- nih.gov
The disease affects pediatric and adult populations, with older adults and individuals with underlying medical comorbidities experiencing the greatest risk of severe disease
- cdc.gov
Clinical manifestations range from asymptomatic infection or mild upper respiratory symptoms—such as fever, cough, fatigue, and anosmia—to acute hypoxemic respiratory failure, acute respiratory distress syndrome (ARDS), thromboembolic events, and death
Personalize your experience
Follow COVID-19 and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.